Sinotau Pharmaceutical Group has raised 320 million yuan ($50 million) in its Series D+ round, while LAV has led a 300 million yuan ($47 million) funding round in In-Vitro Diagnosis (IVD)-driven precision medicine company SH Pinnacles.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
